CCAM
WX

Coupland Cardiff Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Coupland Cardiff Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,000
Closed -$1.94M – 10
2015
Q3 		$1.94M Sell
45,000
-10,000
-18% -$422K 6.29% 5
2015
Q2 		$2.32M Sell
55,000
-186,186
-77% -$7.85M 5.81% 5
2015
Q1 		$9.35M Sell
241,186
-207,175
-46% -$7.98M 20.89% 2
2014
Q4 		$15.1M Sell
448,361
-1,000
-0.2% -$35.3K 21.12% 2
2014
Q3 		$15.7M Buy
449,361
+188,000
+72% +$6.44M 15.66% 3
2014
Q2 		$8.59M Hold
261,361
– – 6.86% 7
2014
Q1 		$9.63M Sell
261,361
-793,639
-75% -$29.1M 6.7% 8
2013
Q4 		$40.5M Buy
1,055,000
+567,600
+116% +$17.9M 27.81% 1
2013
Q3 		$13.4M Buy
+487,400
New +$11.5M 37.16% 1

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Coupland Cardiff Asset Management's WX Position: Q4 2015 in Review

Coupland Cardiff Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 45,000 shares — an estimated $1.94M sold.

Coupland Cardiff Asset Management first reported a position in WX in Q3 2013 and held it in 9 quarters. The position peaked at $40.5M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Coupland Cardiff Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Coupland Cardiff Asset Management sold 45,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.94M.
  • Coupland Cardiff Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 9 quarters.
  • Coupland Cardiff Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $40.5M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Coupland Cardiff Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.